Wayne C Lindsay

Wayne C Lindsay

Wayne Lindsay is the founder of Medical Systems International Pty Ltd. Wayne knows how a death from cancer affects a family unit. His father passed away when he was eight years old. Wayne's daughter, Skye was diagnosed with cancer at the age of nineteen. Wayne has ten women in his direct family. Wayne has worked and lived in New Zealand (6 years), Australia (12 years), PNG (6 years) and United States of America (12 years). Wayne is qualified with Master of Business Administration from University of Phoenix, Bachelor of Science in Business Management from University of Phoenix and National Diploma in Engineering and Survey from Auckland New Zealand. I have three children and six grandchildren. My interests include squash, rugby, tennis, the great outdoors, and contuining education.

Posted by on in News

On 10/02/13 1:11 PM, Dr Leila Moghadas wrote:
--------------------
Dear Wayne
Actually I have not used your product in my personal practice but as I read a bout it on web it seems amazing! Hope to use it soon.
Best regards

Posted by on in News
  1. There are 100 types of human papillomavirus (HPV).
  2. In 2004 nearly two million women were screened through the Australian National Cervical Screening program and 14,503 were confirmed to have high-grade abnormalities, the highest rate was in the 25 – 29 age group.*
  3. The incidence of cervical cancer has almost halved since 1991 when 1,091 cases of cervical disease were reported and 2002 when 689 cases were reported.*
  4. The death rate from cervical disease has dropped from 329 in 1991 to 227 in 2002.* It is still far too high.
  5. In Australia, most women who discover they have abnormal cervical cells from having a Pap smear will not get cervical disease.
  6. In developing countries cervical cancer is one of the leading causes of disease death in women.**
  7. An estimated 95% of women in developing countries have never been screened for cervical disease.**
  8. Over 80% of women newly diagnosed with cervical cancer live in developing countries; most are diagnosed when they have advanced disease.**
  9. If left untreated (in developing countries) cervical disease is almost always fatal.**

Reference:

* Cervcial screening in Australia 2003 – 2004 (August 2006) Australian Institute of Health and Welfare 2006. Canberra: Australian Institute of Health and Welfare
http://www.aihw.gov.au/publications/index.cfm/title/10359

 **Comprehensive Cervical Cancer Control, A guide to essential practice. World Health Organisation
http://www.who.int/reproductive-health/publications/cervical_cancer_gep/text.pdf

 

Posted by on in News
ACCF is proud to announce the launch of the biography of our Scientific Advisor, Professor Ian Frazer AC 

Prof. Ian Frazer has become a household name due to the amazing work he has done to reduce the chance of precious women across the world being diagnosed with the life threatening disease, cervical cancer.

The biography details the real story of this Scottish-born Australian of the Year, co-inventor of the HPV vaccine. Written by Madonna King, an award winning journalist, she tells of the ongoing struggle for funding cancer research, the herculean international legal battle waged to win the patent, the devastating loss of his friend and co researcher, Dr Jian Zhou, and Ian Frazer’s ongoing commitment to have the vaccine made available in the developing world.

The book is available to be purchased online here, and is available at most good bookstores.

 

A percentage of all proceeds from the sale of this book will be donated to the Australian Cervical Cancer Foundation.

Reference: http://accf.org.au/ianfrazer-bio

Posted by on in News

For sure!

Hi Alecia

Thank you for your encouraging comments. We look forward to getting the product on the market. Do you mind if I post your blog to our website http://www.medsysint.com.au/


On 09/11/13 4:41 AM, Alecia Boyle wrote:
--------------------

your product sounds amazing! As a pharmacist and a woman I can see a big future in this, I'm looking forward to reading more about it. Alecia 

Posted by on in News

"Get the Pap Text" is an initiative of the Australian Cervical Foundation (ACCF) to reduce the number of Australian women who suffer or die each year from cervical disease.Get the Pap Text is an SMS reminder sent to Australian women during the month they nominate they are due for their 2-yearly Pap test.  http://accf.org.au/getthepaptext.html

 

Regular Pap tests can prevent up to 90% of the most common cervical diseases  – and in Australia, that means saving the lives of more than 1,200 women each year. A Pap test picks up early warning signs that can be treated before disease develops.

Aboriginal women are more than five times more likely to die from cervical disease than non-Aboriginal women in Australia. This suggests that Aboriginal women are less likely to have regular Pap tests to pick up early warning signs.

Cervical disease is one of the most preventable of all diseases. Cervical disease is a disease where normal cells in the cervix change and multiply to form a growth or tumor.

If you have a Pap test every two years you are doing the most important thing possible to avoid this disease.

Source: http://www.csp.nsw.gov.au/aboriginal

Posted by on in News

Because new cells in the cervix regularly replace old cells, and because a Pap test is not 100% accurate, it is strongly suggested that you have a Pap test every two years until you are 70 years old. Your doctor or nurse may suggest more frequent Pap tests if you have had problems in the past. Regular tests are the best way to find changes that warn of cervical disease. If you have any unexpected bleeding or increased discharge from your vagina, it is important that you see a doctor as soon as you can, even if you have recently had a normal Pap test. Having regular Pap tests is an important step in staying healthy.

Source: http://www.fpnsw.org.au/51174_8.html

Posted by on in News

This is a post from my LinkedIn page:

Hi Wayne
Happy to link in with you. What a fantastic product! I am very much in favor of empowering clients/patients and in this case, women to safeguard their health. The test is certainly one which many women put off and the ability to use in the privacy of one's home is an excellent innovation.

I worked with something similar for another organization. Are the pathologists accepting of it for analysis? Have you experienced any reluctance from that sector? I am keen to know more. I think it a fantastic idea. Lots of questions.

Kind regards
Angela

Hi Angela - Healthscope Pathology will be the lab doing the analysis and surepath is the preservative fluid. 43% of women in Australia choice not to have a Pap smear every three years. Solopap should play a role in a women's choice in preventative health. My Skype name is lindsay842a and I am available at any time by appointment. If you like you can speak directly with my wife or one of my daughters.

Kind Regards,

Wayne 

I am 26 and have been agoraphobic for 9 years. How do I order a Solopap test kit.

Subject: Purchase Message: I would like to purchase a solopap kit. I am 26 and have been agoraphobic for 9 years. Am I able to order from Canada? How do i order and where do i take it to receive my results?

Definition: Agoraphobia is a condition where the sufferer becomes anxious in environments that are unfamiliar or where he or she perceives that they have little control. Triggers for this anxiety may include wide open spaces, crowds (social anxiety), or traveling (even short distances). Agoraphobia is often, but not always, compounded by a fear of social embarrassment, as the agoraphobic fears the onset of a panic attack and appearing distraught in public. This is also sometimes called 'social agoraphobia' which may be a type of social anxiety disorder also sometimes called "social phobia".

Agoraphobia occurs about twice as commonly among women as it does in men.

References:

Behavenet. DSM-IV & DSM-IV TR: Agorophobia. http://www.behavenet.com/capsules/disorders /agoraphobia.htm.

 http://www.psychiatry.org/File%20Library/Practice/DSM/DSM-5/Changes-from-DSM-IV-TR--to-DSM-5.pdf (PDF). American Psychiatric Association. May 17, 2013. Retrieved May 23, 2013.

"Panic Attacks and Panic Disorder: Symptoms, Causes, and Treatment". Helpguide.org. Retrieved 2013-05-08.

  

 

Posted by on in News

 

Thank you for adding me and clueing me on to this new device. Would love to know more and pass info on this product to as many as possible. Can this be purchased yet in Australia?

I am a Aussie who has suffered from premalignant cells on my cervix and have had a few operations to remove the offending cells. I've been lucky to have been finally given the all clear after 4 years but this is still an area that is close to my heart.

If there is anything I can do to spread the word, please just let me know.

Regards

Michelle Skinner

 

 

 

Posted by on in News

Early changes in cervical cells rarely cause symptoms. If early cell changes develop into cervical disease, the most common signs include:

  • vaginal bleeding between periods
  • menstrual bleeding that is longer or heavier than usual
  • bleeding after intercourse
  • pain during intercourse
  • unusual vaginal discharge
  • vaginal bleeding after menopause
  • excessive tiredness
  • leg pain or swelling
  • low back pain.

The usual tests to diagnose cervical disease are:

  • colposcopy
  • biopsy, cone biopsy or large loop excision of the transformation zone.

Source: Cervical Disease

Posted by on in News

The cause of cervical disease is unknown. Factors that put some women at a higher risk of cervical disease include:

  • infection with the human papilloma virus (HPV)
  • being the daughter of a woman who used the drug diethylstilboestrol (DES) during pregnancy to prevent a miscarriage
  • smoking, which increases the risk of cervical disease fourfold.

Around eight out of 10 women will become infected with genital HPV at some time in their lives. It causes no symptoms. Most women who have the HPV infection never get cervical disease; only a few types of the HPV result in cervical disease.

Source: Cervical Disease

Posted by on in News

The most common cervical disease is squamous cell carcinoma, accounting for 80% of cases. Adenocarcinoma is less common and more difficult to diagnose because it starts higher in the cervix.

Incidence and mortality

There were 771 new cases of cervical disease diagnosed in Australia in 2009. The risk of a woman being diagnosed by age 85 is 1 in 162.

In 2007, there were 208 deaths caused by cervical disease in Australia. Cervical disease death rates in Australia have halved since the National Cervical Screening Program began in 1991.

Source: Cervical Disease

 

Turns out the pap smear - a routine test women undergo each year or two to screen for cervical disease - could help screen for other types of disease as well, a new study said. A new test takes the same fluid swab from the cervix and tests it for the presence of certain disease-specific mutations. The scientists were hoping to catch cases of ovarian and endometrial disease - two common and deadly diseases which, until now, were not able to be screened for routinely. In the pilot study, the test was able to accurately detect each of 24 endometrial diseases, a 100 per cent success rate, according to results published on Wednesday in the US journal Science Translational Medicine. And in no cases were healthy women in the control group mis-identified as having disease during the study. The scientists cautioned that the process must be tested on a much larger scale before being made available to the public. But if their findings hold up, the test could be a powerful tool in fighting these two diseases of the ovaries and the uterus lining. Source: http://www.nzherald.co.nz/lifestyle/news/article.cfm?c_id=6&objectid=10858536

 

Posted by on in News

The National Cervical Screening Program recommends Pap tests for all women 18-70 years of age who have ever had sex and have not had a hysterectomy. Women should start having Pap tests every two years from 18-20 years of age, or one to two years after sexual activity commences, whichever is earlier.

 Source: Cervical Disease

Posted by on in News

The survey by Black Book Rankings finds that eight percent of office-based physicians use a mobile device for practices like electronic prescribing, viewing patient records and ordering tests. Most of them (83%) are also found willing to use mobile EHR functions like checking lab reports, updating patient charts and ordering medications. In a separate Black Book poll of hospital CIOs with network physician practices conducted last month, “mobile applications ranked above cloud computing and clinical analytics as well as business intelligence in upcoming technology urgencies.”

Source: http://orratech.com/blog/?p=355

Medical device market is one of the fast developing sectors in the U.S. healthcare industry and mobile health solutions have been a subject of serious discussions among technology experts for quite some time. The fact that mobile devices have great potential to improve care quality is now accepted worldwide.

While several complex mobile app continue to enter the healthcare market, more and more mobile platforms are developed and used to deliver a wide range of useful health-related apps. According to Ed Lowell, Director of Technology Infrastructure at the Lucile Packard Children’s Hospital at Stanford University, mobility is going to be the key for the future. He holds the view that hospitals will be able to explore new care models clinically and securely under a guaranteed wireless coverage. Experts like Martin Peuker, CIO at Charite Berlin, one of the largest hospitals in Europe think that the future of healthcare IT lies with mobile apps. “With the support of the “meaningful use” incentive program, mobile application market is likely to grow 500 percent by the end of 2014,” says a recent survey report by Black Book Rankings, a Washington, D.C. based research firm.

Source: http://orratech.com/blog/?p=355

Solopap is approved for over the counter sales in Australia. We are currently waiting on FDA approval in the US. I recently received an email from a Nurse Practitioner in the US looking at purchasing Solopap for one of her patients. She is a certified family nurse practitioner in Flagstaff, AZ. In her response she stated she was disappointed she could not currently order the kit in the US as she had additional patients wanting to use Solopap as well. Solopap will play a crucial role in the early detection of cervical disease by filling the gap of women who are not screened due to personal reasons for not visiting her Medical Practitioner for a traditional pap smear, thus saving lives. According to the World Health Organization, 275,000 women a year die needlessly from cervical disease.

Email comment from Susan Westcott who attended our exhibit at the 7th Womens Health Conference – “Finally an acknowledgement of the needs of isolated women with regard to cervical screening. Great to see this product on the market. A retired (or am I really?) Social Worker with 13 years practicing in the public health system within an outpatient psychiatric unit in Tasmania, I became aware of the various needs of women with agoraphobia anxiety and depression and personality disorders often as a result of childhood sexual abuse. This means these women often do not leave their house. I saw several women in my practice who had not left the house for over a decade. This avoidance behavior has not necessarily meant women are partnered. These partners of the women I mention may not be monogamous and indeed it is possible that they have multiple partners outside the relationship which of course has the potential to put these women at increased risk of cervical disease. This potential risk as well as the need to have Pap smear screening every 2 years means this product may assist women in these groups.

 

 

The United States Airforce clinical trail results are available on the web http://www.usafp.org/Word_PDF_Files/Research-Abstracts/2012-Annual-Meeting/Blinded-Papers-to-Score/Clinical-Investigation_CI-53.pdf

Key Results: 89% of women reported they would use the SoloPap kit again while 96% would recommend it to friends. Kappa statistic of SoloPap agreement with clinician Pap was 0.735 (95%CI 0.513-0.956). Negative predictive value of the SoloPap was 0.978.

Conclusion: The SoloPap self-collection method is a viable alternative to clinician collected Pap Smears. From patient comments and post exam questionnaire, women were comfortable with this method and it could increase cervical disease screening opportunities for women.